longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

DexCom

DXCM

85.3601.01% ( -0.870 )
Closed: Oct 2, 16:00:01 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 32.22, within the reasonable range, cheaper than 52.69% of the time in the past 1 years, and the industry ranks 31/174, the industry Median -0.93.

32.22xP/E
$85.36Stock price
$2.65Earnings per share
32.22xP/E
Stock price$85.36Earnings per share$2.65

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
32.43x
Typical range
29.67x–36.49x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
ABTUSAbbott Laboratories
31.44x5.13%$169.81B
ISRGUSIntuitive Surgical
44.11x17.25%$138.47B
IDXXUSIDEXX Labs
35.83x12.89%$40.84B
DXCMUSDexCom
32.22x19.08%$32.21B
ITGRUSInteger
33.48x5.33%$4.30B
NVSTUSEnvista
39.66x293.48%$3.77B
OMCLUSOmnicell
39.22x2,358.33%$1.53B
VREXUSVarex Imaging
35.21x127.65%$778.05M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.